Why Excel Is Failing Clinical Vendor Selection And How RFI/RFP Optimization Changes The Game

Source: ClinAI

By Kalyan Obalampalli (KO), founder, ClinAI

Business Partners Negotiating Deal-GettyImages-1424912318

If cost shifts go unnoticed → budgets explode → trials stall.

The real risk in clinical trials isn’t just choosing the wrong vendors—it’s the manual, outdated selection process itself.

The Hidden Problem with “Business as Usual”

In my years in Clinical Operations, I spent countless hours buried in spreadsheets, thinking Excel was “good enough.” I told myself the same things many teams still believe:

  • “Excel works fine—it’s faster to stick with familiar tools.”

  • “We can spot cost discrepancies ourselves.”

  • “Vendors will flag important changes for us.”

At first, it feels efficient.
Then you start missing cost changes, delaying decisions, and risking timelines.

When trials grow in size and complexity, spreadsheets break. You end up with:

  • Hours of frustration on manual reviews

  • Hidden cost overruns

  • Delayed key decisions

I’ve been there—frustrated, watching budgets creep and timelines slip. That’s what pushed me to build Clin.AI.

The Role of RFI/RFP in Vendor Selection

Selecting the right vendors is one of the most important decisions in the clinical trial process, and a well-structured RFI/RFP can be a game changer. Done right, it transforms vendor selection from a reactive process into a strategic advantage.

Why It Matters

  1. Streamlined Selection – Gather detailed vendor information to confirm they meet your trial’s specific needs.

  2. Transparent Pricing – Obtain competitive bids, optimizing costs without compromising quality.

  3. Capability Assessment – Evaluate vendors’ track records, expertise, and innovation to ensure a strong partnership.

  4. Efficiency – Simplify selection and save valuable time and resources.

How to Maximize the Benefits

  1. Start Early – Initiate RFI/RFP well in advance for thorough evaluation.

  2. Be Clear – Define trial requirements and expectations with precision.

  3. Bring in Experts – Involve experienced evaluators for a well-rounded review.

  4. Leverage Technology – Use platforms like Clin.AI to compare vendors side-by-side, making data-driven decisions quickly.

What Changed When We Built Clin.AI

With Clin.AI, we combined RFI/RFP best practices with automated analytics, making vendor selection faster, clearer, and more strategic:

  • Faster vendor comparisons

  • Real-time cost and timeline insights

  • Simplified negotiations

  • Automated compliance documentation

The results speak for themselves:

  • 10% cost savings

  • 8 weeks less vendor selection time

  • Millions saved in some cases by avoiding hidden cost overruns

Why Industry Leaders Are Backing Us

There’s a reason several Heads of Clinical Operations at small to mid-sized biotechs openly support Clin.AI and have written case studies about their results. Many have saved 10% of total cost and cut 8 weeks from vendor selection timelines—sometimes saving millions—because they could compare vendors one-to-one across budgets, timelines, enrollment projections, and more before making a decision.

After all, vendors are the doers, and sponsors are the dreamers. Before you choose your doer, make sure you’re doing it the right way—leveraging technology to optimize one of the biggest spends in your clinical trial.

Don’t just take my word for it—read the case studies written by actual users published on our page at Clinical Leader: https://www.clinicalleader.com/ecommcenter/clinai

What We Do at Clin.AI

Clin.AI is a unified platform for vendor selection and management—from the first RFI/RFP to the last invoice. We help you select the best partner using analytics on budgets, timelines, and projections, then manage that relationship over the life of the study by tracking budgets, change orders, and projections vs. actuals—ensuring your trial stays on time and on budget.

If you’re still stuck in Excel, it’s time to change that. Schedule a demo with us and see how you can select your most important trial partner faster, more accurately, and with complete confidence.

About the author:

Kalyan Obalampalli (KO) is a disruptor and technology innovator with over 20 years of experience in leadership positions in Clinical Operations and Outsourcing at major pharma and biotechs. Having served in advisory roles at start-ups in Silicon Valley, Kalyan has a unique perspective on Clinical Development Operations and how technology can help fill gaps.

Kalyan is the Founder and President of Clin.AI, a disruptive start-up that is revolutionizing the way vendor selection and management is conducted in the biotech / pharma space.